Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 49Session 2025-2026

An Act establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for permits and for dispensing cannabis to patients and caregivers; and making repeals.

Senate Amendment A02574

S0049B1020A02574 NAD:EJH 03/06/26 #90 A02574AMENDMENTS TO SENATE BILL NO. 49Sponsor: SENATOR LAUGHLINPrinter's No. 1020Amend Bill, page 1, by inserting between lines 9 and 10Chapter 2. (Reserved)Amend Bill, page 2, by inserting between lines 6 and 7Section 316. Construction.Chapter 4. (Reserved)Amend Bill, page 2, by inserting between lines 11 and 12Chapter 6. (Reserved)Amend Bill, page 2, lines 13 through 15, by striking out all of said lines and inserting Section 701. Dispensaries.Section 702. Grower/processors.Section 703. Repeals.Section 704. Effective date.Amend Bill, page 2, by inserting between lines 27 and 28CHAPTER 2(Reserved)Amend Bill, page 3, lines 8 through 26, by striking out all of said lines and inserting "Cannabis." As follows:(1) Any of the following:(i) Marijuana, hashish or other substances that are identified as including any parts of the plant cannabis sativa and including derivatives or subspecies, such as indica, of all strains of cannabis, whether growing or not, including the seeds, resin extracted from any part of the plant and any compound, manufacture, salt, derivative, mixture or preparation of the plant. The term includes THC and all other naturally produced cannabinol derivatives, whether produced directly or indirectly by extraction, including delta-7 THC, delta-8 THC, delta-9 THC or any structural, optical or geometric isomers of 2026/90NAD/SB0049A02574 - 1 -12345678910111213141516171819202122232425262728293031 tetrahydrocannabinol, cannabis flower, concentrate, edible and infused products.(ii) A product intended for human consumption with a THC concentration, however derived, that is a hemp-derived cannabinoid product and is excluded from the definition of "hemp" under this section.(iii) An intermediate hemp-derived cannabinoid product which is marketed or sold as a final product or directly to an end consumer for personal or household use.Amend Bill, page 4, lines 2 and 3, by striking out "or industrial hemp as defined in 3 Pa.C.S. § 702" in line 2 and all of line 3 and inserting or industrial hemp.Amend Bill, page 4, by inserting between lines 5 and 6"Container." The innermost wrapping, packaging or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton or cartridge. The term does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use."Final hemp-derived cannabinoid product." A hemp-derived cannabinoid product that is in the final form or preparation marketed or intended to be used or consumed by a human or animal. The term does not include an intermediate hemp-derived cannabinoid product."Hemp." The plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than 0.3% on a dry weight basis. The term:(1) Includes industrial hemp.(2) Does not include:(i) any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of 0.3% in the plant on a dry weight basis;(ii) any intermediate hemp-derived cannabinoid products containing:(A) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;(B) cannabinoids that:(I) are capable of being naturally produced 2026/90NAD/SB0049A02574 - 2 -1234567891011121314151617181920212223242526272829303132333435363738394041424344454647 by a Cannabis sativa L. plant; and(II) were synthesized or manufactured outside the plant; or(C) more than 0.3% combined total of:(I) total tetrahydrocannabinols, including tetrahydrocannabinolic acid; and(II) any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as determined by the board;(iii) any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use; or(iv) any final hemp-derived cannabinoid products containing:(A) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;(B) cannabinoids that:(I) are capable of being naturally produced by a Cannabis sativa L. plant; and(II) were synthesized or manufactured outside the plant; or(C) greater than 0.4 milligrams combined total per container of:(I) total tetrahydrocannabinols, including tetrahydrocannabinolic acid; and(II) any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as determined by the board."Hemp-derived cannabinoid product." The following:(1) Any intermediate or final product derived from hemp, other than industrial hemp, that:(i) contains cannabinoids in any form; and(ii) is intended for human or animal use through any means of application or administration, such as inhalation, ingestion or topical application.(2) The term does not include a drug that is the subject of an application approved under 21 U.S.C. § 355(c) or (j) (relating to new drugs)."Industrial hemp." Hemp:(1) grown for the use of the stalk of the plant, fiber produced from such a stalk or any other non-cannabinoid derivative, mixture, preparation or manufacture of such a stalk;(2) grown for the use of the whole grain, oil, cake, nut, hull or any other non-cannabinoid compound, derivative, mixture, preparation or manufacture of the seeds of such plant;(3) grown for purposes of producing microgreens or other 2026/90NAD/SB0049A02574 - 3 -123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051 edible hemp leaf products intended for human consumption that are derived from an immature hemp plant that is grown from seeds that do not exceed the threshold for total tetrahydrocannabinols concentration specified in the definition of "hemp";(4) that is a plant that does not enter the stream of commerce and is intended to support hemp research at an institution of higher education as defined in 20 U.S.C. § 1001 (relating to general definition of institution of higher education) or an independent research institute; or(5) grown for the use of a viable seed of the plant produced solely for the production or manufacture of any material."Intermediate hemp-derived cannabinoid product." A hemp-derived cannabinoid product which:(1) is not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; or(2) is a powder, liquid, tablet, oil or other product form which is intended or marketed to be mixed, dissolved, formulated or otherwise added to or prepared with or into any other substance prior to administration or consumption.Amend Bill, page 4, by inserting between lines 16 and 17"Transaction scan device." A device capable of deciphering, in an electronically readable format, the information encoded on the magnetic strip or bar code of a State-issued identification card.Amend Bill, page 17, lines 26 through 28, by striking out "A person who has been convicted in any domestic or foreign" in line 26 and all of lines 27 and 28Amend Bill, page 23, lines 12 through 15, by striking out the period in line 12 and all of lines 13 through 15 and inserting not less than two times per month.(2) Advisory committees or subcommittees of the board shall meet as often as deemed necessary by the board.Amend Bill, page 27, lines 16 and 17, by striking out all of said lines and inserting (1) Regulation of cannabis and all its derivatives.(2) Enforcement procedures for cannabis and all its derivatives.Amend Bill, page 27, line 18, by striking out "(2)" and inserting 2026/90NAD/SB0049A02574 - 4 -1234567891011121314151617181920212223242526272829303132333435363738394041 (3)Amend Bill, page 27, line 19, by striking out "(3)" and inserting (4)Amend Bill, page 27, lines 21 through 24, by striking out all of said linesAmend Bill, page 29, lines 15 through 17, by striking out all of said lines and inserting (viii) The board shall not require cannabis business establishments to utilize the board's contracted seed-to-sale vendor as a point-of-sale-system.Amend Bill, page 29, lines 22 and 23, by striking out "and" in line 22 and all of line 23 and inserting and third-party transporters.Amend Bill, page 30, lines 14 through 22, by striking out all of said lines and inserting (xi) Recordkeeping for delivery and receipt of cannabis products.(xii) Procedures for storing cannabis temporarily at warehousing and distribution permit holder facilities.(15) Labeling requirements consistent with industry best practices, including:(i) Standard symbols and warnings where the board shall review symbols from other jurisdictions where cannabis sales are permitted. As national standards are available, the board shall plan to adopt national standards.(ii) An itemization, including weight of all cannabinoid and terpene ingredients specified for the product. The requirements of this subparagraph may be satisfied through the use of electronic QR codes as prescribed by the board.Amend Bill, page 31, lines 19 and 20, by striking out "in" in line 19 and all of line 20 and inserting to be accessible to patients.(21) Testing standards.(22) Permissible forms and concentrations.(23) Restrictions necessary to protect public health and safety.2026/90NAD/SB0049A02574 - 5 -123456789101112131415161718192021222324252627282930313233343536373839 (24) Enforcement against unpermitted cannabinoid products.Amend Bill, page 31, line 30; page 32, lines 1 and 2; by striking out all of said lines on said pages and inserting (1) The board shall have general and sole regulatory authority over the manufacture, processing, testing, distribution and sale of cannabis and all consumable cannabinoid products within this Commonwealth, including products containing hemp-derived cannabinoids, marijuana-derived cannabinoids and synthetic cannabinoids.Amend Bill, page 33, line 27, by inserting after "Act" and this actAmend Bill, page 37, line 5, by striking out "60" and inserting 90Amend Bill, page 39, lines 28 through 30; page 40, lines 1 through 6; by striking out all of said lines on said pages and inserting (a) Unauthorized activities.--(1) A person may not do any of the following:(i) Manufacture, sell, offer for sale, dispense, distribute or market an intermediate hemp-derived product as a final hemp-derived cannabinoid product or directly to an end consumer for personal or household use.(ii) Manufacture, sell, offer for sale, dispense, distribute or market a hemp-derived cannabinoid product that is excluded from the definition of "hemp."(2) In addition to any other penalty provided by Federal or State Law, a person who manufactures, sells or offers for sale, dispenses or distributes cannabis, cannabis concentrates, cannabis flower or any product intended for consumption or inhalation without a permit issued by the board shall be subject to a civil penalty not to exceed $10,000 for each offense. Each day a person engages in unpermitted activity under this subsection shall constitute a separate offense.Amend Bill, page 40, line 12, by striking out the period after "(a)" and inserting or exercise searches, seizures and forfeitures.Amend Bill, page 40, lines 16 and 17, by striking out "or 2026/90NAD/SB0049A02574 - 6 -12345678910111213141516171819202122232425262728293031323334353637383940 revoke the permit of the" in line 16 and all of line 17 and inserting , revoke or deny a license, permit or other authorization to conduct business whatsoever, issued by the local government unit and held by the person or for which the person has made application.Amend Bill, page 42, line 13, by inserting after "appropriated" from the General FundAmend Bill, page 45, by inserting between lines 29 and 30Section 316. Construction.(a) Federal conformity sweep.--Any hemp-derived cannabinoid product that is excluded from the definition of "hemp" under 7 U.S.C. § 1639o (relating to definitions), as amended and effective, shall be deemed "cannabis" for purposes of this act.(b) Compliant hemp products outside board jurisdiction.--A hemp-derived cannabinoid product that meets the definition of "hemp" under this act, including a final hemp-derived cannabinoid product containing not more than 0.4 milligrams combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as determined by the board, shall not be subject to regulation by the board under this act unless and until otherwise provided by the laws of this Commonwealth.CHAPTER 4(Reserved)Amend Bill, page 46, line 5, by striking out "The" and inserting Within 180 days of the effective date of this subsection, theAmend Bill, page 46, line 8, by inserting after "applicants." The board shall issue no more than three warehousing and distribution permits at a time.Amend Bill, page 46, line 19, by striking out "$2,500" and inserting $10,000Amend Bill, page 46, line 29, by inserting after "a"2026/90NAD/SB0049A02574 - 7 -123456789101112131415161718192021222324252627282930313233343536373839 warehousing and distributionAmend Bill, page 47, line 1, by striking out "permit or cultivation center permit." and inserting , clinical registrant or dispensary permit or have a financial interest in an approved laboratory.Amend Bill, page 47, lines 27 through 29, by striking out all of said lines and inserting (a) Issuance.--Within 180 days of the effective date of this subsection, the board shall issue 15 permits to qualified third-party transporters to deliver cannabis products on behalf of permitted dispensaries to patients and caregivers. The board may issue up to 15 additional third-party transporter permits annually. The board shall not require permitted dispensaries to contract with third-party transporter permits to deliver cannabis products.Amend Bill, page 48, line 1, by inserting after "age," possess a valid driver's license,Amend Bill, page 48, by inserting between lines 2 and 3(c) Residency requirement.--At least 51% of the ownership interest in the entity applying for a permit must be held by individuals who have been residents of this Commonwealth for at least two consecutive years immediately prior to the application date.Amend Bill, page 48, line 3, by striking out "(c)" and inserting (d)Amend Bill, page 48, line 5, by striking out "(d)" and inserting (e)Amend Bill, page 48, line 7, by striking out all of said line and inserting (f) Operations.--Amend Bill, page 48, line 12, by striking out "who are 21" and inserting or caregivers who are 21Amend Bill, page 48, line 19, by striking out "10 p.m." and 2026/90NAD/SB0049A02574 - 8 -123456789101112131415161718192021222324252627282930313233343536 inserting 8 p.m.Amend Bill, page 48, line 21, by striking out "(f)" and inserting (g)Amend Bill, page 49, line 5, by striking out "daily" and inserting weeklyAmend Bill, page 49, line 9, by striking out "(g)" and inserting (h)Amend Bill, page 49, lines 10 through 13, by striking out all of said lines and inserting (1) A third-party transporter or dispensary shall verify a patient's certification identity using a valid government-issued photo ID and a valid medical marijuana card at the time of delivery utilizing a transaction scan device.(2) If a third-party transporter or dispensary is delivering to a caregiver on behalf of a patient, the third-party transporter or dispensary shall verify the caregiver's certification, their designation as a caregiver for the patients they are accepting a delivery for using a valid government-issued photo ID and a valid medical marijuana card at the time of delivery utilizing a transaction scan device.(3) A third-party transporter or dispensary:(i) May not sell or share data collected utilizing a transaction scan device.(ii) May use the data collected utilizing a transaction scan device to show the board that the third-party transporter or dispensary is in compliance with this act.Amend Bill, page 49, line 14, by striking out "(2)" and inserting (4)Amend Bill, page 49, line 16, by striking out "(h)" and inserting (i)2026/90NAD/SB0049A02574 - 9 -12345678910111213141516171819202122232425262728293031323334353637 Amend Bill, page 49, line 20, by striking out "Cash or debit card" and inserting ElectronicAmend Bill, page 49, line 21, by striking out "electronically"Amend Bill, page 49, line 24, by striking out "(i)" and inserting (j)Amend Bill, page 49, line 27, by striking out "(j)" and inserting (k)Amend Bill, page 50, line 10, by striking out "(k)" and inserting (l)Amend Bill, page 50, line 17, by striking out all of said line and inserting patients.CHAPTER 6(Reserved)Amend Bill, page 50, line 20, by striking out "Dispensing to patients and caregivers." and inserting Dispensaries.Amend Bill, page 50, lines 21 through 30; page 51, lines 1 through 10; by striking out all of said lines on said pages and inserting The following shall apply:(1) A dispensary permittee shall have a physician, pharmacist, physician assistant or certified nurse practitioner available, either in person or by synchronous interaction to consult with patients and caregivers at all times during the hours the dispensary is open to receive patients and caregivers. If a dispensary permittee has more than one separate location, a single physician, pharmacist, physician assistant or a certified registered nurse practitioner may consult with patients and caregivers, either 2026/90NAD/SB0049A02574 - 10 -1234567891011121314151617181920212223242526272829303132333435 in person or by synchronous interaction, at up to three locations if the locations are licensed under one permit. The permittee shall have in place a plan to demonstrate and maintain compliance with the labor laws of the Commonwealth. A physician, a pharmacist, a physician assistant or a certified registered nurse practitioner shall, prior to assuming duties under this paragraph, successfully complete the course established in section 301(a)(6) of the Medical Marijuana Act. A physician may not issue a certification to authorize patients to receive medical marijuana or otherwise treat patients at the dispensary.(2) A dispensary shall maintain video surveillance equipment in continuous operation, including motion activated video surveillance equipment with pre-motion and post-motion detection capabilities.Section 702. Grower/processors.(a) Remediation.--A grower/processor may apply solvent-based extraction methods and processes to medical marijuana plants that have failed a test conducted by an approved laboratory at harvest, subject to the following:(1) The test failure shall be limited to yeast and mold.(2) The medical marijuana product must pass a final processed test under section 704 of the Medical Marijuana Act.(b) Video surveillance equipment.--Grower/processors shall maintain video surveillance equipment in continuous operation, including motion-activated video surveillance equipment with pre-motion and post-motion detection.Amend Bill, page 51, line 11, by striking out "702" and inserting 703Amend Bill, page 52, line 2, by striking out "703" and inserting 7042026/90NAD/SB0049A02574 - 11 -12345678910111213141516171819202122232425262728293031323334

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.